Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 852738 | ISIN: BE0003739530 | Ticker-Symbol: UNC
Tradegate
02.04.25
20:22 Uhr
162,25 Euro
-0,60
-0,37 %
1-Jahres-Chart
UCB SA Chart 1 Jahr
5-Tage-Chart
UCB SA 5-Tage-Chart
RealtimeGeldBriefZeit
161,45161,6502.04.
162,80163,0002.04.

Aktuelle News zur UCB Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.03.TD Cowen maintains UCB stock Buy rating, EUR250 target11
21.03.UCB Convening Notice to the General Meeting of the Shareholders 2025352CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders to the ordinary general meeting of the shareholders (the "General Meeting") which will be...
► Artikel lesen
UCB Aktie jetzt für 0€ handeln
07.03.Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders10
27.02.UCB beats estimates, sets conservative 2025 guidance with strong pipeline29
20.02.UCB's non-cannabis drug for severe epilepsy gets NHS okay8
14.02.UCB's Bimzelx outpacing AbbVie's Rinvoq, Skyrizi on awareness early in psoriatic arthritis launch: survey27
31.01.IDB Invest joins forces with UCB Power to boost battery production in Brazil9
16.01.UCB Announces Availability Of Single-Injection Administration Option For BIMZELX21
15.01.JPM25, Day 3: AbbVie, UCB, WuXi Biologics and more are set to present21
09.01.UCB Licenses Ailux Biologics AI Platform10
16.12.24UCB's orchestra hits dud note: Novartis-partnered Parkinson's asset fails phase 235
03.12.24UCB, ANB Announce Merger29
02.12.24CBC Group Acquires UCB's Mature Neurology & Allergy Business in China10
02.12.24CBC acquires UCB's neurology and allergy business in China4
30.11.24CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China508CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million.New company is named NeuroGen Pharma, led by an experienced management team with a strong...
► Artikel lesen
20.11.24FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease6
20.11.24Rapid growth spurt for UCB's Bimzelx continues with hidradenitis suppurativa nod marking 5th FDA approval5
20.11.24UCB gets FDA approval for Bimzelx for hidradenitis suppurativa5
20.11.24UCB's BIMZELX Approved by FDA for Treatment of Adults with Hidradenitis Suppurativa3
20.11.24UCB Reports FDA Approval Of BIMZELX In Moderate-to-severe Hidradenitis Suppurativa-
Seite:  Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1